CUSIP: 87424L108
What is CUSIP 87424L108?
CUSIP 87424L108 identifies TLIS - TALIS BIOMEDICAL CORP - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 87424L108:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q3 | 0 | $0 | -$1,606,865 | 0 | |
| 2023 Q2 | 3,348,372 | $1,606,865 | -$4,120,884 | $0.48 | 19 |
| 2023 Q1 | 11,758,102 | $5,761,410 | -$394,949 | $0.49 | 20 |
| 2022 Q4 | 12,577,892 | $5,604,200 | -$30,748 | $0.45 | 24 |
| 2022 Q3 | 12,603,598 | $8,590,382 | -$1,624,267 | $0.68 | 21 |
| 2022 Q2 | 14,910,168 | $12,107,000 | -$1,557,935 | $0.81 | 26 |
| 2022 Q1 | 16,744,609 | $23,617,000 | -$1,333,831 | $1.41 | 40 |
| 2021 Q4 | 17,503,358 | $70,170,000 | -$11,964,983 | $4.01 | 45 |
| 2021 Q3 | 19,058,950 | $119,161,000 | -$6,116,972 | $6.25 | 38 |
| 2021 Q2 | 13,715,030 | $151,277,000 | -$14,668,209 | $11.03 | 42 |
| 2021 Q1 | 20,930,988 | $268,953,000 | +$268,953,000 | $12.85 | 45 |